Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 333

1.

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J.

Am J Kidney Dis. 2000 Sep;36(3):646-61. Review.

PMID:
10977801
2.

Cardiorenal protection in diabetes.

Pickering TG.

Heart Dis. 2000 Mar-Apr;2(2):S18-22. Review.

PMID:
11728259
3.

Responding to the challenge of diabetic nephropathy: the historic evolution of detection, prevention and management.

Vora JP, Ibrahim HA, Bakris GL.

J Hum Hypertens. 2000 Oct-Nov;14(10-11):667-85. Review.

PMID:
11095158
4.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

5.
6.

Maximizing Cardiorenal Benefit in the Management of Hypertension: Achieve Blood Pressure Goals.

Bakris GL.

J Clin Hypertens (Greenwich). 1999 Oct;1(2):141-147.

PMID:
11416606
7.
9.
10.

The importance of blood pressure control in the patient with diabetes.

Bakris GL.

Am J Med. 2004 Mar 8;116 Suppl 5A:30S-38S. Review.

PMID:
15019861
11.

Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.

Björck S, Aurell M.

J Am Soc Nephrol. 1990 Nov;1(5 Suppl 2):S59-63. Review.

PMID:
16989067
12.

Managing hypertension in patients with type 2 diabetes mellitus.

Dobesh PP.

Am J Health Syst Pharm. 2006 Jun 15;63(12):1140-9. Review.

PMID:
16754740
13.

Diabetes and the HOPE study: implications for macrovascular and microvascular disease.

Gerstein HC.

Int J Clin Pract Suppl. 2001 Jan;(117):8-12.

PMID:
11715357
14.

[Are all antihypertensive drugs renoprotective?].

Wolf S, Risler T.

Herz. 2004 May;29(3):248-54. Review. German.

PMID:
15167950
15.
16.

The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy.

McAlister FA, Zarnke KB, Campbell NR, Feldman RD, Levine M, Mahon J, Grover SA, Lewanczuk R, Leenen F, Tobe S, Lebel M, Stone J, Schiffrin EL, Rabkin SW, Ogilvie RI, Larochelle P, Jones C, Honos G, Fodor G, Burgess E, Hamet P, Herman R, Irvine J, Culleton B, Wright JM; Canadian Hypertension Recommendations Working Group.

Can J Cardiol. 2002 Jun;18(6):625-41.

PMID:
12107420
17.

Controlling hypertension in diabetes.

Parving HH.

Acta Diabetol. 2002 Jun;39 Suppl 2:S35-40. Review.

PMID:
12222626
18.

Improving microvascular outcomes in patients with diabetes through management of hypertension.

McGill JB.

Postgrad Med. 2009 Mar;121(2):89-101. doi: 10.3810/pgm.2009.03.1980. Review.

PMID:
19332966
19.

[Therapy of diabetic nephropathy].

Barna I.

Orv Hetil. 2003 Jan 26;144(4):165-72. Review. Hungarian.

PMID:
12621814
20.

Hypertension and diabetes: the scope of the problem.

Parving HH.

Blood Press Suppl. 2001;2:25-31. Review.

PMID:
11465914

Supplemental Content

Support Center